Sorrento OK'd For Alternative $110M Ch. 11 Stock Sale
By Emily Lever · September 12, 2023, 10:30 PM EDT
Bankrupt drug developer Sorrento Therapeutics received a Texas court's approval Tuesday for subsidiary Scilex Holding Co. to buy its own stock back from its parent for $110 million after the original...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login